C07C 251/12
Being acyclic
Official title: being acyclic
C07C251/12 (Being acyclic) appears on 53 US grants and 50 published applications in this corpus.
Search patents in C07C- Granted patents
- 53
- Published applications
- 50
- Assignees
- 30
- Inventors
- 130
- Latest grant
- 1 Oct 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 3 | 4 |
| 2006 | 1 | 5 |
| 2007 | 2 | 1 |
| 2008 | 3 | 1 |
| 2009 | 1 | 3 |
| 2010 | 2 | 2 |
| 2011 | 1 | 2 |
| 2012 | 2 | 2 |
| 2013 | 1 | 2 |
| 2014 | 4 | 6 |
| 2015 | 3 | 4 |
| 2016 | 4 | 2 |
| 2017 | 6 | 3 |
| 2018 | 2 | 3 |
| 2019 | 3 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compound, thin-film forming raw material that contains said compound, and method of manufacturing thin film1 Oct 2024US 12,104,245 B2Adeka Corporation
- Cleavable surfactant31 May 2022US 11,344,493 B2Firmenich SA
- Controlled release oral pharmaceutical dosage forms comprising MGBG5 Jan 2021US 10,881,626 B2Pathologica LLC
- Method for preparing pyrazolecarboxylic acid derivative, and intermediate thereof10 Sep 2019US 10,407,413 B2Zhejiang Yongtai Technology Co., Ltd.
- Alkoxide compound, raw material for forming thin film, method for manufacturing thin film, and alcohol compound16 Jul 2019US 10,351,584 B2Adeka Corporation
- Antiozonant compositions and methods25 Jun 2026US 2026/0176383 A1
- Cerium-ethylenediamine ketone-type and cerium-salen-type complexes and use thereof in organic electronics28 Dec 2023US 2023/0422602 A1Credoxys GmbH
- Novel compound, thin-film forming raw material that contains said compound, and method of manufacturing thin film8 Dec 2022US 2022/0389570 A1Adeka Corporation
- Controlled release oral pharmaceutical dosage forms comprising mgbg25 Mar 2021US 2021/0085625 A1Pathologica LLC
- Fragrance and flavor materials27 Feb 2020US 2020/0062687 A1Takasago International Corporation
Most cited
By later US patents
- Functionalization of polymers via enamine of acetoacetate32US 5,525,662 ARohm and Haas Company · 1996
- Functionalization of polymers via enamine of acetoacetate26US 5,494,975 ARohm and Haas Company · 1996
- Substituted aminobutyric derivatives as neprilysin inhibitors18US 8,263,629 B2Novartis AG · 2012
- Functionalization of polymers via enamine of acetoacetate16US 5,548,024 ARohm and Haas Company · 1996
- Functionalization of polymers via enamine of acetoacetate15US 5,494,961 ARohm and Haas Company · 1996